首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical cancer research

缩写:CLIN CANCER RES

ISSN:1078-0432

e-ISSN:1557-3265

IF/分区:10.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11950条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Joshi J Alumkal,Leigh Ellis Joshi J Alumkal
In March 2026, Ipsen voluntarily withdrew the EZH2 inhibitor tazemetostat (Tazverik) from all markets and indications following results from the confirmatory Phase Ib/III SYMPHONY-1 trial demonstrating hematologic second primary malignancie...
Matteo Repetto,Michael V Gormally,Jason Chang et al. Matteo Repetto et al.
Purpose: The clinical implications of distinct SMARCA4 alteration classes remain incompletely defined. We performed a pan-cancer analysis to characterize SMARCA4 mutation classes and their associations with allelic status...
S Daniel Haldar,Meredith Wetzel,Jiayun Lu et al. S Daniel Haldar et al.
Purpose: Pancreatic adenosquamous carcinoma (ASQ) is a rare variant with poorly defined clinical and molecular features compared to conventional pancreatic ductal adenocarcinoma (PDAC). This study aimed to characterize th...
Steven Blinka,Sonali Arora,Dmytro Rudoy et al. Steven Blinka et al.
Purpose: Treatment intensification with androgen receptor pathway inhibitors (ARPIs) has become the standard of care for patients with metastatic prostate cancer. However, there remains an unmet need to identify biomarker...
Kristoffer S Rohrberg,Mariana Brandão,Eduardo Castañón Álvarez et al. Kristoffer S Rohrberg et al.
Purpose: Rilvegostomig, an anti-PD-1/TIGIT bispecific antibody, was evaluated in this first-in-human, multicenter, phase I/II, open-label study (NCT04995523) in checkpoint inhibitor (CPI)-experienced patients with program...
Céline Chauvin,Ryszard Wimmer,Ludovica Brunetti et al. Céline Chauvin et al.
Purpose: Rhabdoid tumors (RTs) are highly aggressive pediatric cancers driven by the biallelic inactivation of the SMARCB1 tumor suppressor gene, the sole recurrent genetic alteration. SMARCB1 encodes a core subunit of th...
Joseph J Zhao,Choong-Kun Lee,Allison S Y Chan et al. Joseph J Zhao et al.
Purpose: Claudin 18.2 (CLDN18.2), a tight junction protein normally expressed in gastric epithelium and rendered accessible during malignant transformation, has emerged as a key therapeutic target. Here, we seek to charac...
Shruti U Gandhy,Sandra J Casak,May Tun Saung et al. Shruti U Gandhy et al.
On May 15, 2025, the Food and Drug Administration approved retifanlimab in combination with carboplatin and paclitaxel for treating unresectable or metastatic squamous cell carcinoma of the anal canal (SCAC), and as a single agent for secon...
Jennifer Y Sheng,Marianna L Zahurak,Faith Too et al. Jennifer Y Sheng et al.
Purpose: Behavioral weight loss interventions (BWL) consisting of remote coaching and self-monitoring have limited effectiveness in breast cancer (BC) survivors. We conducted a single-arm phase II study evaluating additio...